https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520KeyBanc%2520Conference%2520w%2520nonGAAP.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated
savings and operational benefits from the asset realignment;
Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;
Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition
being accretive;
Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability
and cost of credit in the future;
The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with
inadequate liquidity) to maintain their credit availability;
The speed and extent of an economic recovery, including the recovery of the housing market;
Our ability to achieve new business gains;
The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;
Changes in polymer consumption growth rates in the markets where we conduct business;
Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;
Fluctuations in raw material prices, quality and supply and in energy prices and supply;
Production outages or material costs associated with scheduled or unscheduled maintenance programs;
Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working
capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;
An inability to raise or sustain prices for products or services;
An inability to maintain appropriate relations with unions and employees;
The inability to achieve expected results from our acquisition activities;
Our ability to continue to pay cash dividends;
The amount and timing of repurchases of our common shares, if any; and
Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates
and changes in the rate of inflation
https://www.avient.com/sites/default/files/2021-02/laser-marking-and-percept-case-study.pdf
As a result, these legal costs became
a significant and completely unforeseen drain on
finances.
https://www.avient.com/sites/default/files/2024-07/Versaflex TPE for Orthopedic Sole Insert - Application Snapshot.pdf
ORTHOPEDIC PARTS
MANUFACTURER
O R T H O P E D I C S O L E I N S E R T
• A super soft TPE (
https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-design-guide-.pdf
The shot size
of the machine needs to be large enough to fill
the part completely and allow for a cushion.
Optimizing Injection Velocity
The objective of this step is to find where the
injection velocity will fill out the part completely,
and not pressure limit the machine.
PLET 350 – Plastic Part Design, Jason Williams, Spring 2014, Penn State Erie, The Behrend College.
2.
https://www.avient.com/sites/default/files/2023-06/AVIENT_TPEs and LSR eBook.pdf
Though the viscosity of TPEs are reduced when processed at high shear
rates, TPEs must be “packed” into a mold to ensure complete fill-out.
The results were impressive:
• Better tension set, improved compression and enhanced permeability
• Slashed $70,000 from production costs by reducing cycle times and
eliminating assembly steps
• Lower specific gravity of TPEs trimmed overall part weight, which cut
$36,000 in annual freight costs
• Reprocessability of TPEs shrank scrap rates, saving more than $70,000
in material waste
SWITCH TO TPEs
BOOSTS BOTTOM LINE
CASE
STUDY
READ MORE
ONLINE
For a manufacturer seeking to redesign a liquid injection-molded silicone medical
pump valve insert, Avient suggested custom-formulated grades of Dynalloy™ OBC
and Versaflex™ TPEs that would deliver better multi-functional performance than
the previous design, while also facilitating easier two-shot molding.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Press Release-1.pdf
I’m incredibly proud of the two transformational portfolio enhancements completed during 2022,”
Mr.
To access Avient’s news library online, please visit www.avient.com/news.
https://www.avient.com/sites/default/files/2025-02/News Release - AVNT-2024.12.31-News Release 2.12.25 2PM_0.pdf
To access Avient’s news library online, please visit www.avient.com/news.
Further, as a result of Avient's strategic shift to an innovator
of materials solutions, it has completed several acquisitions and divestitures which have resulted in a significant amount of
intangible asset amortization.
https://www.avient.com/sites/default/files/2024-10/Avient Announces Third Quarter 2024 Results.pdf
To access Avient’s news library online, please visit www.avient.com/news-events.
Further, as a result of Avient's portfolio shift to a pure play
specialty formulator, it has completed several acquisitions and divestitures which have resulted in a significant amount of
intangible asset amortization.
https://www.avient.com/sites/default/files/2025-05/Avient Announces First Quarter 2025 Results_0.pdf
To access Avient’s news library online, please visit www.avient.com/news.
Further, as a result of Avient's strategic shift to an innovator of materials solutions, it has
completed several acquisitions and divestitures which have resulted in a significant amount of intangible asset amortization.
https://www.avient.com/sites/default/files/resources/US_Clinton_RC14001_2020Exp.pdf
has been assessed by ABS Quality Evaluations,Inc. and found to be in conformance with the requirements set forth by:
RC14001®:2015
COMPOUNDING OF THERMOPLASTIC PRODUCTS
Certificate No: 55287
Effective Date: 07 December 2017
Expiration Date: 06 December 2020
Issue Date: 07 December 2017 Alex Weisselberg, President
Validity of this certificate is based on the successful completion of the periodic surveillance audits of the management system defined by the above scope and is contingent upon
prompt,written notification to ABS Quality Evaluations, Inc. of significant changes to the management system or components thereof.